X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (119) 119
humans (74) 74
india (59) 59
infectious diseases (58) 58
microbiology (54) 54
drug resistance (45) 45
immunology (43) 43
antibiotics (38) 38
infections (37) 37
antimicrobial agents (35) 35
drug resistance in microorganisms (35) 35
microbial sensitivity tests (35) 35
antimicrobial resistance (32) 32
surveillance (30) 30
anti-bacterial agents - pharmacology (29) 29
health aspects (29) 29
epidemiology (27) 27
india - epidemiology (27) 27
male (26) 26
genes (25) 25
children (23) 23
female (23) 23
hospitals (23) 23
research (22) 22
genetic aspects (21) 21
laboratories (21) 21
mortality (20) 20
nosocomial infections (20) 20
pharmacology & pharmacy (20) 20
pathogens (19) 19
public health (19) 19
resistance (19) 19
risk factors (19) 19
studies (19) 19
anti-bacterial agents - therapeutic use (18) 18
bacteria (18) 18
medical research (18) 18
middle aged (18) 18
original (18) 18
pneumonia (18) 18
drug resistance, bacterial (17) 17
infectious and parasitic diseases (17) 17
medicine (17) 17
adult (16) 16
colistin (16) 16
enterobacteriaceae (16) 16
vaccines (16) 16
bacterial infections and mycoses (15) 15
beta-lactamases - genetics (15) 15
genomes (15) 15
klebsiella (15) 15
bacterial proteins - genetics (14) 14
biochemical phenomena, metabolism, and nutrition (14) 14
diagnosis (14) 14
e coli (14) 14
medicine, research & experimental (14) 14
multilocus sequence typing (14) 14
prokaryotes (14) 14
antiinfectives and antibacterials (13) 13
bacteremia (13) 13
infection (13) 13
medicine, general & internal (13) 13
prevalence (13) 13
research article (13) 13
acinetobacter baumannii (12) 12
bla (12) 12
carbapenems (12) 12
escherichia-coli (12) 12
mutation (12) 12
patients (12) 12
plasmids (12) 12
public, environmental & occupational health (12) 12
salmonella (12) 12
bacterial infections (11) 11
child, preschool (11) 11
cloning (11) 11
disease (11) 11
fever (11) 11
genotype (11) 11
klebsiella pneumoniae (11) 11
minimum inhibitory concentration (11) 11
penicillin (11) 11
pseudomonas aeruginosa (11) 11
serotypes (11) 11
streptococcus infections (11) 11
whole genome sequencing (11) 11
adolescent (10) 10
bacterial pneumonia (10) 10
carbapenemase (10) 10
care and treatment (10) 10
disease control (10) 10
drug resistance, multiple, bacterial - genetics (10) 10
gram-negative bacteria (10) 10
infant (10) 10
infant, newborn (10) 10
polycyclic compounds (10) 10
staphylococcus infections (10) 10
virulence (10) 10
young adult (10) 10
analysis (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2019, Volume 64, Issue 2
ABSTRACT The discovery of antibiotics in the last century is considered one of the most important achievements in the history of medicine. Antibiotic usage has... 
Journal Article
The Lancet, ISSN 0140-6736, 07/2018, Volume 392, Issue 10142, pp. 145 - 159
More than 500 000 neonatal deaths per year result from possible serious bacterial infections (pSBIs), but the causes are largely unknown. We investigated the... 
INJECTABLE PROCAINE BENZYLPENICILLIN | POPULATION-BASED INCIDENCE | SEVERE BACTERIAL-INFECTION | MEDICINE, GENERAL & INTERNAL | EQUIVALENCE TRIAL | SYNCYTIAL VIRUS-INFECTION | SUB-SAHARAN AFRICA | GROUP-B STREPTOCOCCUS | OPEN-LABEL | SIMPLIFIED ANTIBIOTIC REGIMENS | CLINICAL SIGNS | Virus Diseases - epidemiology | Community-Acquired Infections - etiology | Community-Acquired Infections - epidemiology | Bacterial Infections - etiology | Humans | Middle Aged | Child, Preschool | Infant | Male | Pregnancy Outcome - epidemiology | Incidence | Young Adult | Pakistan | Adult | Female | Infant, Premature, Diseases - epidemiology | Infant, Newborn | Community-Acquired Infections - mortality | Risk Factors | Infant, Premature, Diseases - etiology | India | Virus Diseases - etiology | Pregnancy | Bangladesh | Adolescent | Bacterial Infections - epidemiology | Developing Countries | Virus Diseases - mortality | Causality | Population Surveillance | Bacterial Infections - mortality | Cohort Studies | Infants | Bacterial infections | Analysis | Patient outcomes | Low income groups | Neonates | Rubella | Identification methods | Communities | Physicians | Gentamicin | Viruses | Infections | Drug resistance | Sustainable development | Blood | Developing countries--LDCs | Streptococcus infections | Prevention | Chlamydia | Penicillin | Bacteria | Children | Nosocomial infections | Blood culture | Medical personnel | Mortality | Antimicrobial agents | Molecular chains | Children & youth | Studies | Charities | Babies | Respiratory syncytial virus | Antibiotics | Surveillance | Workers | Ampicillin | Influenza | Sepsis | Viral infections
Journal Article
Journal of Clinical and Diagnostic Research, ISSN 2249-782X, 08/2017, Volume 11, Issue 8, pp. DL03 - DL04
Journal Article
Journal Article
by Lo, Stephanie W and Gladstone, Rebecca A and van Tonder, Andries J and Lees, John A and du Plessis, Mignon and Benisty, Rachel and Givon-Lavi, Noga and Hawkins, Paulina A and Cornick, Jennifer E and Kwambana-Adams, Brenda and Law, Pierra Y and Ho, Pak Leung and Antonio, Martin and Everett, Dean B and Dagan, Ron and von Gottberg, Anne and Klugman, Keith P and McGee, Lesley and Breiman, Robert F and Bentley, Stephen D and Brooks, Abdullah W and Corso, Alejandra and Davydov, Alexander and Maguire, Alison and Pollard, Andrew and Kiran, Anmol and Skoczynska, Anna and Moiane, Benild and Beall, Bernard and Sigauque, Betuel and Aanensen, David and Lehmann, Deborah and Faccone, Diego and Foster-Nyarko, Ebenezer and Bojang, Ebrima and Egorova, Ekaterina and Voropaeva, Elena and Sampane-Donkor, Eric and Sadowy, Ewa and Bigogo, Godfrey and Mucavele, Helio and Belabbès, Houria and Diawara, Idrissa and Moïsi, Jennifer and Verani, Jennifer and Keenan, Jeremy and Nair Thulasee Bhai, Jyothish N and Ndlangisa, Kedibone M and Zerouali, Khalid and Ravikumar, K L and Titov, Leonid and De Gouveia, Linda and Alaerts, Maaike and Ip, Margaret and de Cunto Brandileone, Maria Cristina and Hasanuzzaman, Md and Paragi, Metka and Nurse-Lucas, Michele and Ali, Mushal and Elmdaghri, Naima and Croucher, Nicholas and Wolter, Nicole and Porat, Nurit and Eser, Özgen Köseoglu and Akpaka, Patrick E and Turner, Paul and Gagetti, Paula and Tientcheu, Peggy-Estelle and Carter, Philip E and Mostowy, Rafal and Kandasamy, Rama and Ford, Rebecca and Henderson, Rebecca and Malaker, Roly and Shakoor, Sadia and Grassi Almeida, Samanta Cristine and Saha, Samir K and Doiphode, Sanjay and Madhi, Shabir A and Devi Sekaran, Shamala and Srifuengfung, Somporn and Obaro, Stephen and Clarke, Stuart C and Nzenze, Susan A and Kastrin, Tamara and Ochoa, Theresa J and Balaji, Veeraraghavan and Hryniewicz, Waleria and Urban, Yulia and The Global Pneumococcal Sequencing Consortium and Global Pneumococcal Sequencing Con and Global Pneumococcal Sequencing Consortium
The Lancet Infectious Diseases, ISSN 1473-3099, 07/2019, Volume 19, Issue 7, pp. 759 - 769
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e103253
Objectives: To determine the in vitro activity of antibiotics, including arbekacin, cefminox, fosfomycin and biapenem which are all still unavailable in India,... 
ACINETOBACTER-BAUMANNII | URINARY-TRACT-INFECTIONS | MULTIDRUG-RESISTANT | NORTH-INDIA | MULTIDISCIPLINARY SCIENCES | ESCHERICHIA-COLI | SUSCEPTIBILITY | CARBAPENEM | RESISTANT PSEUDOMONAS-AERUGINOSA | IN-VITRO ACTIVITY | ENTEROBACTERIACEAE | Dibekacin - analogs & derivatives | Prospective Studies | Fosfomycin - pharmacology | Escherichia coli - drug effects | Humans | Pseudomonas aeruginosa - physiology | Acinetobacter - physiology | Pseudomonas aeruginosa - drug effects | Thienamycins - pharmacology | Acinetobacter - drug effects | Klebsiella - physiology | India | Dibekacin - pharmacology | Gram-Negative Bacterial Infections - microbiology | Gram-Negative Bacteria - drug effects | Cephamycins - pharmacology | Klebsiella - drug effects | Drug Resistance, Multiple, Bacterial | Anti-Bacterial Agents - pharmacology | Escherichia coli - physiology | Gram-Negative Bacteria - physiology | Microbial Sensitivity Tests - methods | Escherichia coli | Fosfomycin | Klebsiella | Microbiology | Amikacin | Colistin | Laboratories | Clinical trials | Clinical isolates | Infections | Drug resistance | Ethics | Cefminox | E coli | Piperacillin | Pseudomonas aeruginosa | Bacteria | Inhibition | Urine | Medical research | Bacterial infections | Staphylococcus infections | Antimicrobial agents | Arbekacin | Dilution | Hospitals | Antibiotics | Tazobactam | Sputum | Minimum inhibitory concentration | Clinical medicine | Biapenem | Tigecycline | Carbapenems
Journal Article